Anticancer agents that inhibit tumor growth by targeting a regulatory protein called CDK4 might actually promote the development and progression of certain B-cell lymphomas, according to a new study led by researchers at ...
Mar 20, 2014
0
0
(Medical Xpress)—A cancer patient from Bolton with a rare form of Non-Hodgkin's Lymphoma is in remission after becoming the first person outside of the US to trial a new cancer drug, Brentuximab Vedotin, led by University ...
Mar 10, 2014
0
0
Follicular lymphoma is a type of non-Hodgkin's lymphoma– a blood cancer - that usually develops slowly. The majority of patients are diagnosed when their disease is at an advanced stage.
Feb 25, 2014
0
0
Genetic profiling has painted the clearest picture yet of how a type of blood cancer – follicular lymphoma – develops and changes from a manageable disease into an aggressive cancer, offering new targets for treatment, ...
Dec 23, 2013
0
0
(HealthDay)—Imbruvica (ibrutinib) has been approved by the U.S. Food and Drug Administration to treat mantle cell lymphoma (MCL), a rare but aggressive form of blood cancer.
Nov 13, 2013
0
0
New research shows that children with an inherited genetic defect in a critical anti-inflammatory pathway have a genetic predisposition to lymphoma. Results of the study, published online today in Blood, the Journal of the ...
Oct 2, 2013
0
0
Follicular lymphoma is often caused by a translocation between chromosomes 14 and 18, resulting in the overexpression of a cancer-causing gene called BCL-2. A research team co-led by A*STAR scientists recently revealed another ...
Sep 25, 2013
0
0
People who are married when diagnosed with cancer live longer than those who are not, report researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital. Married patients also tended to have cancers diagnosed ...
Sep 23, 2013
0
0
Young children who live near nuclear power plants do not have a greater risk of developing childhood leukaemia or non-Hodgkin Lymphoma according to research published in the British Journal of Cancer today (Friday).
Sep 13, 2013
1
0
A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug. ...
Sep 10, 2013
0
0
